Deloitte will look into a range of issues that also underpinned the 2019 review led by Professor Lloyd Sansom AO, including the "effectiveness, efficiency and appropriateness of the work delivered by NPS MedicineWise" and its governance and administrative arrangements. …
New review of NPS Medicinewise a virtual 're-run' of previous process
July 13, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
AZ to maintain breast cancer therapy on the PBS for six months despite price rise knocked back
September 24, 2026 - -
England's genomics chief to share NHS lessons during Australia visit
September 24, 2026 - - Latest News -
AbbVie’s top lawyer publicly makes the case against German pricing
September 24, 2026 - -
AI is already in the decision-making process, but where is the conversation about its use?
September 24, 2026 - -
Blood test for eight cancers arrives in Australia, but misses almost half of them
September 23, 2026 - -
Prescient raises $6 million to carry cancer drug PTX-100 past a key dosing decision
September 23, 2026 - - Australian Biotech -
Seven Australian startups share $15.6 million to take on dementia
September 23, 2026 - - Australian Biotech